Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. (Q51541351)
Jump to navigation
Jump to search
scientific article published in March 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. |
scientific article published in March 2005 |
Statements
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties (English)
Christian P Larsen
Thomas C Pearson
Paul Tso
Nozomu Shirasugi
Elizabeth Strobert
Dan Anderson
Shannon Cowan
Karen Price
Joseph Naemura
John Emswiler
JoAnne Greene
Lori Ann Turk
Robert Townsend
David Hagerty
Peter S Linsley
Robert J Peach